Time to Implantable Cardioverter Defibrillator in Patients With Left Ventricular Ejection Fraction ≤ 35%

被引：0
|
作者：
Gomez, Jackeline P. Vajta
Elbey, Mehmet
Borz-Baba, Carolina I.
Gnanaraj, Joseph
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13009
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
    Rizzello, Vittoria
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : I139 - I142
  • [2] Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
    Rizzello, Vittoria
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : I139 - I142
  • [3] Do patients with a left ventricular ejection fraction between 30% and 35% benefit from a primary prevention implantable cardioverter defibrillator?
    Al-Khatib, Sana M.
    Han, Joo Y.
    Edwards, Rex
    Bardy, Gust H.
    Bigger, J. Thomas
    Buxton, Alfred E.
    Cappato, Riccardo
    Dorian, Paul
    Hallstrom, Al
    Kadish, Alan H.
    Kudenchuk, Peter J.
    Lee, Kerry L.
    Mark, Daniel B.
    Moss, Arthur J.
    Steinman, Richard
    Inoue, Lurdes Y. T.
    Sanders, Gillian D.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (01) : 253 - 254
  • [4] Improvement of Left Ventricular Ejection Fraction After Surgical Revascularization in Patients Eligible for Implantable Cardioverter Defibrillator
    Naksuk, Niyada
    Carlson, Selma
    Gravely, Amy
    Buelt-Gebhardt, Melissa
    Madjid, Mohammad
    Adabag, Selcuk
    [J]. CIRCULATION, 2021, 144
  • [5] Effect of Implantable Cardioverter-Defibrillator on Left Ventricular Ejection Fraction in Patients With Idiopathic Dilated Cardiomyopathy
    Schaer, Beat
    Theuns, Dominic A.
    Sticherling, Christian
    Szili-Torok, Tamas
    Osswald, Stefan
    Jordaens, Luc
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (11): : 1640 - 1645
  • [6] Trajectory of left ventricular ejection fraction among individuals eligible for implantable cardioverter-defibrillator
    Carlson, Selma
    Gravely, Amy
    Adabag, Selcuk
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2021, 44 (05): : 800 - 806
  • [7] Association between implanted cardioverter-defibrillator and mortality for patients with left ventricular ejection fraction near 35%
    Wasfy, J.
    Achanta, A.
    Hidrue, M. K.
    Urbut, S.
    Axtell, A. L.
    Berman, A. B.
    Chen, C.
    Gustus, S.
    Picard, M. H.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
  • [8] Left Ventricular Ejection Fraction as Criterion for Implantation of an Implantable Cardioverter-Defibrillator in Heart Failure Patients Undergoing Surgical Left Ventricular Reconstruction
    Mollema, Sjoerd A.
    Klein, Patrick
    Heersche, Jogien
    Schalij, Martin J.
    Van der Wall, Ernst E.
    Versteegh, Michel I. M.
    Klautz, Robert J. M.
    Van Erven, Lieselot
    Bax, Jeroen J.
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (07): : 913 - 917
  • [9] Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction
    Judson, Gregory L.
    Cohen, Beth E.
    Muniyappa, Anoop
    Raitt, Merritt H.
    Shen, Hui
    Tarasovsky, Gary
    Whooley, Mary A.
    Dhruva, Sanket S.
    [J]. AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 19
  • [10] Implantable cardioverter defibrillator outcome: beyond ejection fraction?
    Cygankiewicz, Iwona
    [J]. EUROPACE, 2013, 15 (04): : 467 - 470
12345